Pfizer Hit With COVID-19 Vaccine Patent Infringement Lawsuit
Pfizer used technologies developed by another company in its COVID-19 vaccine, infringing on patents, according to a new ...
Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer used technologies developed by another company in its COVID-19 vaccine, infringing on patents, according to a new ...
None Arbutus Biopharma Corporation (NASDAQ: ABUS) and its licensee Genevant Sciences have sued Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ:…
Vice Chancellor Nathan Cook of the Delaware Chancery Court said the purchase agreement "clearly and unambiguously" left Merck liable for claims related to products, including Dr. Scholl's foot powder, sold before the transaction closed. Gilead details promising early COVID antiviral data, setting up larger studies Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials of the drug that have begun enrolling patients.
Arbutus Biopharma on Tuesday sued Pfizer and BioNTech in a New Jersey district court, claiming their mRNA COVID-19 vaccines infringe five of Arbutus' patents.
Independent Community Bankers of America is rolling out a new campaign aimed at shoring up small lenders in the wake of last month’s bank collapses.